These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 36698706)

  • 1. Frequency of COVID-19 vaccine side effects and its associated factors among the vaccinated population of Pakistan: A cross-sectional study.
    Yasmin F; Najeeb H; Siddiqui HF; Asghar MS; Awan HA; Usama RM; Allahuddin Z; Tahir MJ; Ullah K; Mahmmoud Fadelallah Eljack M
    Health Sci Rep; 2023 Jan; 6(1):e1071. PubMed ID: 36698706
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reported Adverse Effects and Attitudes among Arab Populations Following COVID-19 Vaccination: A Large-Scale Multinational Study Implementing Machine Learning Tools in Predicting Post-Vaccination Adverse Effects Based on Predisposing Factors.
    Hatmal MM; Al-Hatamleh MAI; Olaimat AN; Mohamud R; Fawaz M; Kateeb ET; Alkhairy OK; Tayyem R; Lounis M; Al-Raeei M; Dana RK; Al-Ameer HJ; Taha MO; Bindayna KM
    Vaccines (Basel); 2022 Feb; 10(3):. PubMed ID: 35334998
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety and tolerability of the novel 2019 coronavirus disease (COVID-19) vaccines among people with epilepsy (PwE): A cross-sectional study.
    Massoud F; Ahmad SF; Hassan AM; Alexander KJ; Al-Hashel J; Arabi M
    Seizure; 2021 Nov; 92():2-9. PubMed ID: 34391030
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Common Systemic and Local Adverse Effects of the Sinovac COVID-19 Vaccine: An Observational Study From Pakistan.
    Chohan HK; Jamal A; Mubeen M; Khan MU; Junaid M; Chohan MK; Imran A; Aslam A; Anwar A; Hashmi AA
    Cureus; 2023 May; 15(5):e38564. PubMed ID: 37284387
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A First Report on Side-Effects of COVID-19 Vaccines among General Population in Sudan: A Cross-Sectional Analysis.
    Mohamed MS; Mohamed AO; Alenazy R; Khan YH; Idriss MT; Alhudaib NAA; Elsaman T; Mohamed MA; Eltayib EM; Mallhi TH
    Vaccines (Basel); 2023 Jan; 11(2):. PubMed ID: 36851192
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Prevalence of Side Effects of Sinopharm COVID-19 Vaccine: An Experience From Pakistan.
    Haider T; Abidi SRZ; Fatima M; Zafar A; Siddiqui RQU; Khan W; Saeed T; Anwar A; Hashmi AA
    Cureus; 2023 Apr; 15(4):e38180. PubMed ID: 37252607
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and Short-Term Safety of COVID-19 Vaccines: A Cross-Sectional Study on Vaccinated People in the UAE.
    AlHamaidah MA; Noureldin N; Yehia A; Alani I; Al-Qussain A; Abdou O; Ashames A; Kharaba Z
    Vaccines (Basel); 2022 Dec; 10(12):. PubMed ID: 36560566
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reported COVID-19 vaccines side effects among Jordanian population: a cross sectional study.
    Omeish H; Najadat A; Al-Azzam S; Tarabin N; Abu Hameed A; Al-Gallab N; Abbas H; Rababah L; Rabadi M; Karasneh R; Aldeyab MA
    Hum Vaccin Immunother; 2022 Dec; 18(1):1981086. PubMed ID: 34614383
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intricacies Affiliated With Post-COVID Vaccine Complications in Makkah Province, Saudi Arabia.
    Sheriff MM; Basalib SG; Mereani MJ; Bakhsh LM; Alzamzami BA; Garout RM
    Cureus; 2022 Dec; 14(12):e32749. PubMed ID: 36578849
    [TBL] [Abstract][Full Text] [Related]  

  • 10. COVID-19 Vaccination Trends and Side Effects among Egyptian Hemodialysis Patients: A Multicenter Survey Study.
    Nassar MK; Salem KM; Elgamal M; Abdel-Gawad SM; Tharwat S
    Vaccines (Basel); 2022 Oct; 10(10):. PubMed ID: 36298635
    [TBL] [Abstract][Full Text] [Related]  

  • 11. COVID-19 Vaccine Hesitancy and Acceptance Among Individuals With Cancer, Autoimmune Diseases, or Other Serious Comorbid Conditions: Cross-sectional, Internet-Based Survey.
    Tsai R; Hervey J; Hoffman K; Wood J; Johnson J; Deighton D; Clermont D; Loew B; Goldberg SL
    JMIR Public Health Surveill; 2022 Jan; 8(1):e29872. PubMed ID: 34709184
    [TBL] [Abstract][Full Text] [Related]  

  • 12. COVID-19 vaccination side effects among the child age group: a large cross-sectional online based survey in Saudi Arabia.
    Alwafi H; Naser AY; Aldhahir AM; Alhazmi A; Alosaimi AN; Mandili RA; Majeed Z; Salawati E; Ekram R; Samannodi M; Assaggaf H; Almatrafi M; Alqahtani JS; Alsanosi SM; Minshawi F
    BMC Infect Dis; 2022 Dec; 22(1):911. PubMed ID: 36474174
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adverse Effects of Sinopharm COVID-19 Vaccine among Vaccinated Medical Students and Health Care Workers.
    Meo AS; Masood A; Shabbir U; Ali H; Nadeem Z; Meo SA; Alshahrani AN; AlAnazi S; Al-Masri AA; Al-Khlaiwi T
    Vaccines (Basel); 2023 Jan; 11(1):. PubMed ID: 36679950
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of framing and communicating COVID-19 vaccine side-effect risks on vaccine intentions for adults in the UK and the USA: A structured summary of a study protocol for a randomized controlled trial.
    Sudharsanan N; Favaretti C; Hachaturyan V; Bärnighausen T; Vandormael A
    Trials; 2021 Sep; 22(1):592. PubMed ID: 34488843
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of COVID-19 vaccines (Sputnik V, AZD-1222, and Covaxin) side effects among healthcare workers in Birjand city, Iran.
    Zare H; Rezapour H; Mahmoodzadeh S; Fereidouni M
    Int Immunopharmacol; 2021 Dec; 101(Pt B):108351. PubMed ID: 34801416
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of Side Effects of the AstraZeneca COVID-19 Vaccine: A Multicenter Experience From Pakistan.
    Haider T; Ali J; Ali SM; Iftikhar AS; Siddiqui AA; Khan AS; Qamar JA; Sohail K; Anwar A; Hashmi AA
    Cureus; 2023 Oct; 15(10):e46543. PubMed ID: 37927680
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The prevalence of AstraZeneca COVID-19 vaccine side effects among Nigist Eleni Mohammed memorial comprehensive specialized hospital health workers. Cross sectional survey.
    Desalegn M; Garoma G; Tamrat H; Desta A; Prakash A
    PLoS One; 2022; 17(6):e0265140. PubMed ID: 35749520
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A randomized, double-blind, placebo-controlled phase III clinical trial to evaluate the efficacy and safety of SARS-CoV-2 vaccine (inactivated, Vero cell): a structured summary of a study protocol for a randomised controlled trial.
    Akova M; Unal S
    Trials; 2021 Apr; 22(1):276. PubMed ID: 33849629
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reactogenicity of COVID-19 Vaccines in Patients With a History of COVID-19 Infection: A Survey Conducted in Pakistan.
    Riyyan M; Sarwar HA; Chania HA; Sajid S; Hotwani S; Sarwar HU; Nawaz S; Abid S
    Cureus; 2022 Nov; 14(11):e31359. PubMed ID: 36514568
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prospective Evaluation of Side-Effects Following the First Dose of Oxford/AstraZeneca COVID-19 Vaccine among Healthcare Workers in Saudi Arabia.
    Darraj MA; Al-Mekhlafi HM
    Vaccines (Basel); 2022 Jan; 10(2):. PubMed ID: 35214681
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.